Vistagen Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTGN and other ETFs, options, and stocks.About VTGN
Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia).
VTGN Key Statistics
Stock Snapshot
The current Vistagen Therapeutics(VTGN) stock price is $0.62, with a market capitalization of 24.44M. The stock trades at a price-to-earnings (P/E) ratio of -0.41.
As of 2026-03-18, Vistagen Therapeutics(VTGN) stock has fluctuated between $0.61 and $0.65. The current price stands at $0.62, placing the stock +0.9% above today's low and -5.1% off the high.
Vistagen Therapeutics(VTGN) shares are trading with a volume of 233.78K, against a daily average of 538.32K.
In the last year, Vistagen Therapeutics(VTGN) shares hit a 52-week high of $5.14 and a 52-week low of $0.43.
In the last year, Vistagen Therapeutics(VTGN) shares hit a 52-week high of $5.14 and a 52-week low of $0.43.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.